• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis

Lisa Swanson, MD, FAAD, discusses how pediatric atopic dermatitis (AD) treatment challenges include limited approved options, safety concerns, and adherence issues. Effective management requires balancing new therapies like Janus kinase (JAK) inhibitors with safety while supporting caregivers through education.

Video Player is loading.
Current Time 0:00
Duration 1:59
Loaded: 0%
Stream Type LIVE
Remaining Time 1:59
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    This news content has been independently developed and is not endorsed by the American Academy of Dermatology.

    Video content above is prompted by the following:

    • What are the biggest challenges you face when treating pediatric AD, particularly in younger children?
    © 2025 MJH Life Sciences

    All rights reserved.